InvestorsHub Logo
Followers 697
Posts 34944
Boards Moderated 3
Alias Born 05/30/2011

Re: stockdawg44 post# 183

Monday, 03/05/2018 7:14:01 AM

Monday, March 05, 2018 7:14:01 AM

Post# of 1039
CLSD - 11.80 up 59.90% premarket on news. Big gap.


Clearside Biomedical announces positive topline results from its pivotal Phase 3 clinical trial of suprachoroidal CLS-TA in patients with macular edema associated with non-infectious uveitis CLSD 
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APRN News